Substance abuse and the management of medication nonadherence in schizophrenia

Journal of Nervous and Mental Disease

Volumn 194, Issue 6, 2006, Pages 454-457

  Wilk, Joshua ^a,d   Marcus, Steven C ^b   West, Joyce ^a   Countis, Lisa ^a   Hall, Rebecca ^a   Regier, Darrel A ^a   Olfson, Mark ^c  

^a AMERICAN PSYCHIATRIC ASSOCIATION   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^d NONE   (United States)

Author keywords

Antipsychotic medication; Nonadherence; Schizophrenia; Substance use disorder

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; AGED; ARTICLE; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DENIAL; DRUG TREATMENT FAILURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PSYCHIATRIC TREATMENT; PSYCHIATRIST; SCHIZOPHRENIA; STATISTICAL SIGNIFICANCE; SUBSTANCE ABUSE; TREATMENT INDICATION; TREATMENT RESPONSE;

ADULT; ANTIPSYCHOTIC AGENTS; ATTITUDE TO HEALTH; COMORBIDITY; DELAYED-ACTION PREPARATIONS; DENIAL (PSYCHOLOGY); DIAGNOSIS, DUAL (PSYCHIATRY); DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; HUMANS; PATIENT EDUCATION; PHYSICIAN'S PRACTICE PATTERNS; PROFESSIONAL-FAMILY RELATIONS; PSYCHIATRY; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SUBSTANCE-RELATED DISORDERS; TREATMENT REFUSAL;

EID: 33745236703     PISSN: 00223018     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.nmd.0000221289.54911.63     Document Type: Article

References (15)

1. Barrowclough C, Haddock G, Tarrier N, Lewis SW, Moring J, O'Brien R, Schofield N, McGovern J (2001) Randomized controlled trial of motivational interviewing, cognitive behavior therapy and family intervention for patients with comorbid schizophrenia and substance use disorders. Am J Psychiatry. 158:1706-1713.
2. Drake RE, Essock SH, Shaner A, Carey KB, Minkoff K, Kola L, Lynde D, Osher FC, Clark RE, Rickards L (2001) Implementing dual diagnosis services for clients with severe mental illness. Psychiatr Serv. 52:469-476.
3. Drake RW, Wallach MA (1989) Substance abuse among the chronic mentally ill. Hosp Commun Psychiatry. 40:1041-1046.
4. Fenton WS, Blyler CR, Heinssen RK (1997) Determinants of medication compliance in schizophrenia: Empirical and clinical findings. Schizophr Bull. 23:637-651.
5. Hunt GE, Bergen J, Bashir M (2002) Medication compliance and comorbid substance abuse in schizophrenia: Impact on community survival 4 years after a relapse. Schizophr Res. 54:253-264.
6. Kemp R, Kirov G, Everitt B, Hayward P, David A (1998) Randomized controlled trial of compliance therapy: 18-month follow-up. Br J Psychiatry. 172:413-419.
7. Lacro JP, Dunn LB, Dolder CR, Leckban SG, Jeste DV (2002) Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: A comprehensive review of recent literature. J Clin Psychiatry. 63:892-909.
8. Merrill JO, Rhodes LA, Deyo RA, Marlatt GA, Bradley KA (2002) Mutual mistrust in the medical care of drug users: The keys to the "narc" cabinet. J Gen Intern Med. 17:327-333.
9. Moos RH (2005) Iatrogenic effects of psychosocial interventions for substance use disorders: Prevalence, predictors, prevention. Addiction. 100:595-604.
10. Mueser KT, Corrigan PW, Hilton DW, Tanzman B, Schaub A, Gingerich S, Essock SM, Tarrier N, Morey B, Vogel-Scibilia S, Herz MI (2002) Illness management and recovery: a review of research. Psychitr Serv. 53:1272-1284.
11. Noordsy D, Green A (2003) Pharmacotherapy for schizophrenia and co-occurring substance use disorders. Curr Psychiatry Rep. 5:340-346.
12. Olfson M, Mechanic D, Hansell S, Boyer CA, Walkup J, Weiden PJ (2000) Predicting medication noncompliance after hospital discharge among patients with schizophrenia. Psychiatr Serv. 51:216-222.
13. Owen RR, Fischer EP, Booth BM, Cuffel BJ (1996) Medication noncompliance and substance abuse among patients with schizophrenia. Psychiatr Serv. 47:853-858.
14. Salyers MP, Mueser KT (2001) Social functioning, psychopathology and medication side effects in relation to substance use and abuse in schizophrenia. Schizophr Res. 48:109-123.
15. Swofford CD, Kasckow JW, Scheeler-Gilkey G, Inderbitzin LB (1996) Substance use: A powerful predictor of relapse in schizophrenia. Schizophr Res. 20:145-151.